Abstract
Background Aortic stenosis (AS) is associated with increasing severity of diastolic dysfunction as measured by conventional echocardiographic grading. The parameterized diastolic filling (PDF) method can describe diastolic function mechanistically, by analyzing filling using the physics of classical mechanics for spring recoil.
Purpose To use the PDF method to describe the mechanics of how diastolic dysfunction manifests in AS.
Methods Patients (n=73) undergoing echocardiography were included according to AS of varying severity (normal/mild AS: maximum Doppler velocity across aortic valve (Vmax) <3.0 m/s, moderate/severe AS: Vmax≥3.0 m/s). Analysis of pulsed wave Doppler transmitral E-waves was performed using freely available software for PDF analysis.
Results Compared to normal/mild AS (n=41), patients with moderate/severe AS (n=32) had a left ventricle with a greater interventricular septal thickness (p=0.02) and higher E/e’ (p=0.007), but similar left ventricular ejection fraction (p=0.10) and left atrial volume index (p=0.21). PDF analysis (48±9 E-waves per patient) showed that moderate/severe AS did not differ in myocardial stiffness (p=0.70), but had a higher myocardial viscoelasticity (p=0.02), higher load (p=0.04), longer derived time constant of isovolumetric pressure decay (tau, p=0.004), higher filling energy (p=0.02), higher peak driving (p=0.02) and resistive (p=0.004) force of filling, lower kinematic filling efficiency index (p<0.001), but no difference in the load-independent index of diastolic function (p=0.62).
Conclusions AS was primarily associated with a greater damping of LV recoil (viscoelasticity) and load, but without a change in myocardial stiffness. Diastolic dysfunction in AS manifests with pathophysiological changes that are mechanistically consistent with a greater severity of diastolic dysfunction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was funded in part by the Swedish Research Council, Swedish Heart and Lung Foundation, Stockholm County Council, Karolinska Institutet, Heart Research Australia, New South Wales Health, and the University of Sydney.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the UnitingCare Health Human Research Ethics Committee (Ref: 2024.02.396) with a retrospective waiver of individual subject informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
